Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung

Stomach Neoplasms

Carcinoma, Hepatocellular

Neoplasm Metastasis, Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms, Rectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Astrocytoma, Glioma

Ovarian Neoplasms, Recurrence

Carcinoma, Hepatocellular, Liver Neoplasms

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Melanoma

Colorectal Neoplasms

Hyperthermia, Digestive System Neoplasms

Colorectal Neoplasms

Metastatic Colorectal Adenocarcinoma

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Cholangiocarcinoma

Lung Neoplasms

Arthritis, Autoimmune Diseases, Endocrine System Diseases, Eye Diseases, Heart Diseases, Myositis, Neoplasms

Clinical Trials

Priming Immunotherapy in Advanced Disease With Radiation

CIML NK Cell in Head & Neck Cancer

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

PRIMM

Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy

PLATINUM

Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1

Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer

PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety

AUTENTIC

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

CLASSIC5

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

START-FIT

EXIT

CHEERS

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

HEAIS001

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT

Postoperative Adjuvant Therapy of HCC Based on PD-1

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

The Prediction Biomarkers of Survival Outcome for Severe Immune-related Hepatitis

CHIMeRA